137 related articles for article (PubMed ID: 37481233)
41. Analysis of circulating breast cancer cell heterogeneity and interactions with peripheral blood mononuclear cells.
Brechbuhl HM; Vinod-Paul K; Gillen AE; Kopin EG; Gibney K; Elias AD; Hayashi M; Sartorius CA; Kabos P
Mol Carcinog; 2020 Oct; 59(10):1129-1139. PubMed ID: 32822091
[TBL] [Abstract][Full Text] [Related]
42. Detection of live circulating tumor cells by a class of near-infrared heptamethine carbocyanine dyes in patients with localized and metastatic prostate cancer.
Shao C; Liao CP; Hu P; Chu CY; Zhang L; Bui MH; Ng CS; Josephson DY; Knudsen B; Tighiouart M; Kim HL; Zhau HE; Chung LW; Wang R; Posadas EM
PLoS One; 2014; 9(2):e88967. PubMed ID: 24551200
[TBL] [Abstract][Full Text] [Related]
43. Current and future role of circulating tumor cells in patients with epithelial ovarian cancer.
Van Berckelaer C; Brouwers AJ; Peeters DJ; Tjalma W; Trinh XB; van Dam PA
Eur J Surg Oncol; 2016 Dec; 42(12):1772-1779. PubMed ID: 27265041
[TBL] [Abstract][Full Text] [Related]
44. CTC phenotyping for a preoperative assessment of tumor metastasis and overall survival of pancreatic ductal adenocarcinoma patients.
Sun Y; Wu G; Cheng KS; Chen A; Neoh KH; Chen S; Tang Z; Lee PF; Dai M; Han RPS
EBioMedicine; 2019 Aug; 46():133-149. PubMed ID: 31375425
[TBL] [Abstract][Full Text] [Related]
45. Seeding metastases: The role and clinical utility of circulating tumour cells.
Patel DA; Blay J
Tumour Biol; 2021; 43(1):285-306. PubMed ID: 34690152
[TBL] [Abstract][Full Text] [Related]
46. Insulin-like growth factor-1 receptor (IGF-1R) expression on circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial.
Gennari A; Foca F; Zamarchi R; Rocca A; Amadori D; De Censi A; Bologna A; Cavanna L; Gianni L; Scaltriti L; Rossi E; Facchinetti A; Martini V; Bruzzi P; Nanni O
Breast Cancer Res Treat; 2020 May; 181(1):61-68. PubMed ID: 32200486
[TBL] [Abstract][Full Text] [Related]
47. Associations between AR-V7 status in circulating tumour cells, circulating tumour cell count and survival in men with metastatic castration-resistant prostate cancer.
Belderbos BPS; Sieuwerts AM; Hoop EO; Mostert B; Kraan J; Hamberg P; Van MN; Beaufort CM; Onstenk W; van Soest RJ; Martens J; Sleijfer S; de Wit R; Mathijssen RHJ; Lolkema MP
Eur J Cancer; 2019 Nov; 121():48-54. PubMed ID: 31542641
[TBL] [Abstract][Full Text] [Related]
48. Clinical significance of circulating tumor cells (CTCs) with respect to optimal cut-off value and tumor markers in advanced/metastatic breast cancer.
Shiomi-Mouri Y; Kousaka J; Ando T; Tetsuka R; Nakano S; Yoshida M; Fujii K; Akizuki M; Imai T; Fukutomi T; Kobayashi K
Breast Cancer; 2016 Jan; 23(1):120-127. PubMed ID: 24906662
[TBL] [Abstract][Full Text] [Related]
49. Detection of circulating tumor cells in metastatic and clinically localized urothelial carcinoma.
Flaig TW; Wilson S; van Bokhoven A; Varella-Garcia M; Wolfe P; Maroni P; Genova EE; Morales D; Lucia MS
Urology; 2011 Oct; 78(4):863-7. PubMed ID: 21813167
[TBL] [Abstract][Full Text] [Related]
50. Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients.
Lu J; Fan T; Zhao Q; Zeng W; Zaslavsky E; Chen JJ; Frohman MA; Golightly MG; Madajewicz S; Chen WT
Int J Cancer; 2010 Feb; 126(3):669-83. PubMed ID: 19662651
[TBL] [Abstract][Full Text] [Related]
51. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition.
Gorges TM; Tinhofer I; Drosch M; Röse L; Zollner TM; Krahn T; von Ahsen O
BMC Cancer; 2012 May; 12():178. PubMed ID: 22591372
[TBL] [Abstract][Full Text] [Related]
52. Color-coded Imaging of the Circulating Tumor Cell Microenvironment.
Satake T; Suetsugu A; Nakamura M; Kunisada T; Shimizu M; Saji S; Moriwaki H; Hoffman RM
Anticancer Res; 2018 Oct; 38(10):5635-5638. PubMed ID: 30275181
[TBL] [Abstract][Full Text] [Related]
53. Circulating Tumor Cells (CTCs): A Unique Model of Cancer Metastases and Non-invasive Biomarkers of Therapeutic Response.
Liu J; Lian J; Chen Y; Zhao X; Du C; Xu Y; Hu H; Rao H; Hong X
Front Genet; 2021; 12():734595. PubMed ID: 34512735
[TBL] [Abstract][Full Text] [Related]
54. Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells.
Zheng S; Lin H; Liu JQ; Balic M; Datar R; Cote RJ; Tai YC
J Chromatogr A; 2007 Aug; 1162(2):154-61. PubMed ID: 17561026
[TBL] [Abstract][Full Text] [Related]
55. The gate to metastasis: key players in cancer cell intravasation.
Sznurkowska MK; Aceto N
FEBS J; 2022 Aug; 289(15):4336-4354. PubMed ID: 34077633
[TBL] [Abstract][Full Text] [Related]
56. Gene signatures of circulating breast cancer cell models are a source of novel molecular determinants of metastasis and improve circulating tumor cell detection in patients.
Fina E; Cleris L; Dugo M; Lecchi M; Ciniselli CM; Lecis D; Bianchi GV; Verderio P; Daidone MG; Cappelletti V
J Exp Clin Cancer Res; 2022 Feb; 41(1):78. PubMed ID: 35216615
[TBL] [Abstract][Full Text] [Related]
57. Circulating Tumor Cells: Does Ion Transport Contribute to Intravascular Survival, Adhesion, Extravasation, and Metastatic Organotropism?
Stock C
Rev Physiol Biochem Pharmacol; 2022; 182():139-175. PubMed ID: 35137308
[TBL] [Abstract][Full Text] [Related]
58. Pancreatic cancer circulating tumor cells: applications for personalized oncology.
DiPardo BJ; Winograd P; Court CM; Tomlinson JS
Expert Rev Mol Diagn; 2018 Sep; 18(9):809-820. PubMed ID: 30099926
[TBL] [Abstract][Full Text] [Related]
59. Circulating Tumor Cells Exhibit Metastatic Tropism and Reveal Brain Metastasis Drivers.
Klotz R; Thomas A; Teng T; Han SM; Iriondo O; Li L; Restrepo-Vassalli S; Wang A; Izadian N; MacKay M; Moon BS; Liu KJ; Ganesan SK; Lee G; Kang DS; Walmsley CS; Pinto C; Press MF; Lu W; Lu J; Juric D; Bardia A; Hicks J; Salhia B; Attenello F; Smith AD; Yu M
Cancer Discov; 2020 Jan; 10(1):86-103. PubMed ID: 31601552
[TBL] [Abstract][Full Text] [Related]
60. Pathophysiology of Tumor Cell Release into the Circulation and Characterization of CTC.
Todenhöfer T; Pantel K; Stenzl A; Werner S
Recent Results Cancer Res; 2020; 215():3-24. PubMed ID: 31605221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
